Case Report: Durable complete response of advanced-stage hepatocellular carcinoma to DEB−TACE combined with lenvatinib and camrelizumab

Case Report: Durable complete response of advanced-stage hepatocellular carcinoma to DEB−TACE combined with lenvatinib and camrelizumab

BackgroundHepatocellular carcinoma (HCC) with lung metastases is associated with a poor prognosis due to limited effective treatment options. Emerging evidence suggests that combining locoregional therapy, multi-kinase inhibitors (MKIs), and immune checkpoint inhibitors (ICIs) offers promising resul...

Full description

Saved in:
Bibliographic Details
Main Authors: Baiguo Xu, Yufeng Cui, Ning Wang, Zhongsong Gao, Qing Ye, Huiling Xiang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Immunology
Subjects:
hepatocellular carcinoma
locoregional therapy
drug eluting beads-TACE
immunotherapy
lenvatinib
camrelizumab
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1549675/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2025.1549675/full

Similar Items